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Summary  The  Ewing-like  variation  of  adamantinoma  is  a  rare  entity,  leading  to  challenge  its
differential  diagnosis,  notably  with  Ewing’s  sarcoma.  We  are  reporting  a  case  of  a  20-year-old
male who  presented  with  swelling  in  the  left  leg  that  had  progressed  over  a  2-year  period.  X-rays
revealed  a  tumour  in  the  tibia  that  was  intracortical,  osteolytic,  multilocular  and  invaded  the
soft tissues.  A  surgical  biopsy  was  performed.  Histopathology  examination  showed  a  tumour
growth with  small  round  cells  expressing  CD99.  A  diagnosis  of  Ewing’s  sarcoma  was  made.
Since the  patient  declined  surgical  treatment,  chemotherapy  was  administered.  Two  years  later,
the patient  returned  because  the  tumour  had  grown  in  size.  A  second  biopsy  was  performed.
Microscopic  evaluation  showed  a  tumour  growth  with  osteoﬁbrous  and  epithelial  components,
which expressed  pankeratin  and  vimentin,  but  was  negative  for  CD99.  A  diagnosis  of  Ewing-like
adamantinoma  was  made.
©  2012  Published  by  Elsevier  Masson  SAS.
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Adamantinoma  is  a  rare  bone  tumour  in  young  adults  that
usually  affects  the  diaphysis  of  the  tibia.  This  is  a  low-grade,
malignant  tumour,  which  histologically  appears  as  a  biphasic
tumour  with  intermingled  epithelial  and  osteoﬁbrous  com-
ponents.  A  differential  diagnosis  with  other  lesions  (both
benign  and  malignant)  can  be  challenging  to  make  based
only  the  histopathology.  The  diagnosis  is  even  more
challenging  when  this  growth  looks  like  a  round  cell  tumour.
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doi:10.1016/j.otsr.2012.06.015e  are  reporting  here  on  a  rare  case  of  Ewing-like  adamanti-
oma.
bservation
his  is  the  case  of  a  20-year-old  male  who  presented  with
welling  on  the  anterior  aspect  of  the  left  leg,  which  had
ecome  more  evident  over  a  2-year  period.  Clinical  exam-
nation  revealed  a soft,  painless  swollen  area,  5  cm  in
iameter,  on  the  anterior  aspect  of  the  left  leg,  without  signs
f  inﬂammation  or  satellite  lymphadenopathy.  Standard  X-
ays  showed  an  intracortical,  osteolytic,  multilocular  lesion
ith  peripheral  sclerosis  on  the  anterior  tibia  that  extended
orward  into  the  soft  tissues  and  had  a  vacuolar,  ‘‘soap-
ubble’’  like  appearance.  MRI  showed  an  aggressive  tumour
.
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Figure  1  MRI:  a:  frontal  reconstruction  showing  the  surface
lesion without  medullary  canal  involvement;  b:  T1  after  gadolin-
ium injection:  intracortical  lesion  invading  the  soft  tissues  and
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Figure  2  Swelling  on  the  anterior  aspect  of  the  left  leg.
Figure  3  Standard  X-rays  of  the  leg:  intracortical,  osteolytic
lesion  invading  the  soft  tissues.  Note  the  polycystic  nature  giv-
ing a  ‘‘soap-bubble’’  appearance  in  the  images  and  an  ‘‘apple
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tarting  from  the  anteromedial  cortex  of  the  tibia,  invad-
ng  most  of  the  soft  tissues,  but  not  affecting  the  medullary
anal  (Fig.  1).
A  surgical  biopsy  was  performed.  Histopathology  showed
 tumour  growth  with  diffuse  layers  of  small,  round,
onomorphic  cells,  with  little  cytoplasm,  a  round  nucleus
nd  thin  chromatin.  The  stroma  was  ﬁbrous  and  highly  vas-
ularized.  Immunohistochemistry  showed  that  the  tumour
ells  were  intensely  and  diffusely  stained  for  CD99  and
imentin,  and  to  a  lesser  degree  for  S100  proteins.  Based
n  these  morphological  and  immunohistochemical  fea-
ures,  a  diagnosis  of  Ewing’s  sarcoma  was  made.  The
atient  underwent  four  rounds  of  chemotherapy.  Amputa-
ion  of  the  leg  was  then  proposed  to  the  patient,  who
efused.
Two  years  later,  the  patient  returned  because  the  tumour
ad  increased  in  size.  Physical  examination  showed  a swollen
rea,  17  cm  in  diameter,  on  the  anterior  aspect  of  the  left
eg  that  was  soft  and  slightly  painful  (Fig.  2).  Standard
-rays  showed  intracortical  osteolysis  with  cortex  rupture
nd  extension  to  the  soft  tissues  (Fig.  3).  MRI  showed  a
arge  superﬁcial  lesion  starting  at  the  cortex  with  signiﬁcant
nvolvement  of  the  soft  tissues,  having  cavities  separated
y  T1  and  T2  hyposignal  partitions.  These  cavities  had
uid-ﬂuid  levels  suggestive  of  associated  aneurysmal  cysts
Fig.  4).
Based  on  the  lengthy  progression  and  radiological  appear-
nce  of  the  lesion,  the  diagnosis  of  Ewing’s  sarcoma  was
isputed.  A  second  surgical  biopsy  was  performed.  Micro-
copic  evaluation  showed  a  tumour  growth  organized  in
ayers  and  streaks,  within  abundant  ﬁbrous  and  collagenous
troma  (Fig.  5).  The  tumour  cells  were  basophilic,  cohe-
ive,  rounded,  polygonal  or  fusiform.  In  some  areas,  clear
pithelial  differentiation  was  noted.  There  was  moder-
te  atypism  and  many  mitotic  cells.  Immunohistochemistry
howed  that  the  tumour  cells  expressed  both  keratin
nd  vimentin  (Figs.  6  and  7)  and  were  negative  for
a
m
wore’’ appearance  that  is  easily  seen  on  the  X-ray  (b).
D99.  A  diagnosis  of  Ewing-like  adamantinoma  was  then
ade.
No  distant  metastasis  was  found.  The  tumour  was  excised
urgically  as  a  whole  block.  Reconstruction  was  performed
ith  a  translated  ipsilateral  vascularized  ﬁbula;  an  external
xator  was  used  for  stabilisation.  The  ﬁxator  was  removed
fter  1  year  and  a  walking  boot  was  used  for  the  next  6
onths.  Three  years  after  the  surgery,  the  patient  was  doing
ell.
Ewing-like  adamantinoma  847
Figure  4  MRI:  frontal  reconstruction  without  (a)  and  with
(b) gadolinium  injection  and  axial  slice  (c):  polycystic  corti-
cal lesion  with  changes  to  the  medullary  canal  signal.  Note  the
appearance  of  the  ﬂuid-ﬂuid  level  (c).
Figure  5  Tumour  growth,  epithelial  in  nature,  organized  in
layers and  streaks,  within  abundant  ﬁbrous  and  collagenous
stroma  (HE,  100  ×).
Figure  6  Tumour  cells  expressing  keratin  (IHC,  400  ×).
Figure  7  Tumour  cells  expressing  vimentin  (IHC,  200  ×).
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Immunocytochemical analysis of Ewing’s tumors. Patterns of48  
iscussion
damantinoma  is  a  rare,  low-grade,  malignant  tumour  that
onsists  0.4%  of  all  primary  bone  tumours  and  affects  the
iaphysis  of  the  tibia  in  85  to  90%  of  cases  [1].  It  can  occur
t  any  age,  but  mostly  affects  young  adults  (average  age
f  25  to  35  years),  with  men  being  affected  slightly  more
ften  than  women  [1].  Clinically,  adamantinoma  presents  as
welling  of  the  leg  that  has  slowly  increased  in  size  over  time
nd  may  or  may  not  be  painful  [1].  X-rays  usually  show  an
steolytic,  intracortical  lesion,  often  having  multiple  parti-
ions  giving  it  a  ‘‘soap-bubble’’  like  appearance;  the  lesion
s  surrounded  by  peripheral  sclerosis  [1].  Histopathology  is
equired  for  a  positive  diagnosis.  Adamantinoma  is  char-
cterized  histologically  by  a  biphasic  growth  with  various
mounts  of  intermingled  epithelial  and  osteoﬁbrous  compo-
ents.  In  classic  adamantinoma,  the  epithelial  component
as  four  potential  morphological  variations:  basaloid,  tubu-
ar,  squamoid  and  spindle  cell.  A  ﬁfth  histological  subtype
an  be  distinguished  from  classic  adamantinoma  and  is  char-
cterised  by  a  large  amount  of  osteoﬁbrous  tissue.
The  Ewing-like  form  is  a  rare  variant  of  adamantinoma,
ith  only  ﬁve  cases  described  in  the  published  literature
2—5]. It  is  characterised  by  a  growth  of  small,  round,
niform  cells  that  express  both  epithelial  and  neural  cell
mmunohistochemical  markers,  including  those  typical  of
wing’s  sarcoma  (CD99+).  These  cells  also  have  ultrastruc-
ural  characteristics  of  both  epithelial  and  neuroendocrine
ells  [2,3,6,7].
The  histogenesis  of  this  tumour  is  not  clear,  but  the
ost  likely  hypothesis  is  that  this  adamantinoma  variation
s  issued  from  the  same  multipotent  cell  line  that  is  at  the
ource  of  Ewing’s  sarcoma.  In  fact,  the  latter  is  known  to
ave  the  ability  to  differentiate  into  either  mesenchymal,
pithelial  or  neural  cell  lines  [8—10]. This  would  explain  the
ouble  phenotype  (epithelial  and  neuro-ectodermal)  of  this
umour.
As  would  be  expected  from  its  name,  Ewing-like
damantinoma  results  in  diagnostic  challenges  relative  to
lassic  Ewing’s  sarcoma.  In  our  case,  this  led  to  a  delayed
iagnosis  and  inadequate  treatment.  However,  the  patient’s
ge,  tibial  placement  of  the  tumour  and  intracortical  loca-
ion  should  guide  the  pathologist  to  look  for  the  expression
f  epithelial  immunohistochemical  markers.
A  differential  diagnosis  is  even  harder  to  make  with
damantinoma-like  Ewing’s  sarcoma.  This  is  a  rare  type  of
wing’s  sarcoma  that,  other  than  showing  neuro-ectodermal
ifferentiation,  shows  morphological,  ultrastructural  and/or
mmunohistochemical  characteristics  of  epithelial  tumours.
t  is  essential  for  these  two  entities  to  be  distinguished
s  the  prognosis  and  treatment  are  different.  In  the  most
ifﬁcult  cases,  the  differential  diagnosis  is  based  on  cytoge-
etic  studies  to  identify  the  genetic  abnormalities  typical
f  Ewing’s  sarcoma,  notably  (11;22)  translocation  and/or
WS/FLI1  or  EWS/ERG  fusion  genes  [1,11—13].  These  genetic
bnormalities  are  not  present  in  adamantinoma  [1,14].
We  did  not  perform  a  cytogenetic  study  for  our  case.
owever,  the  clinical,  radiological  and  especially  progres-
ion  data  provided  sufﬁcient  information  for  this  tumour  to
e  labeled  as  Ewing-like  adamantinoma.  Histological  assess-
ent  of  the  tumour  after  2  years  of  progression  revealed  aM.M.  Hamdane  et  al.
ifferent  morphological  appearance  than  that  of  the  initial
umour:  there  was  a  predominant  epithelial  component,  the
ound  cells  had  disappeared  and  there  was  no  CD99  expres-
ion.
Treatment  approaches  for  Ewing-like  adamantinoma
ave  not  yet  been  standardized,  given  how  rare  this  entity
s.  In  our  reported  case,  the  treatment  approach  was  similar
o  treatment  of  a  classic  adamantinoma;  a  wide  resection
f  the  tumour  was  performed.
onclusion
he  Ewing-like  form  of  adamantinoma  is  a  rare  vari-
nt.  The  aetiology  of  this  pathology  is  not  yet  known.
he  histopathology  diagnosis  is  difﬁcult.  However,  when  a
umour  appears  in  the  tibia  of  a  young  adult  and  has  an
ntracortical  location,  a  diagnosis  of  adamantinoma  must
e  considered  and  further  immunohistochemistry  work  must
e  done  to  look  for  expression  of  epithelial  markers.  In
he  most  challenging  cases,  molecular  biology  studies  can
ow  be  done  on  deparafﬁnised  tissues,  which  would  help
o  differentiate  between  adamantinoma  and  Ewing’s  sar-
oma.
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